TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
Lennart Versemann, Elisabeth Heßmann(Nephrologisches Zentrum Goettingen)
Cited by 17
Related Papers
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies
|Gastroenterology|2023|14
NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming
|Cellular and Molecular Gastroenterology and Hepatology|2023|8